Content about dialysis

September 4, 2012

Impax settles with Genzyme over kidney dialysis drugs

Generic drug maker Impax Labs has settled with a subsidiary of Sanofi regarding generic versions of two drugs for dialysis patients, Impax said Tuesday.

April 10, 2012

Amgen to acquire Kai for $315 million

Biotech manufacturer Amgen will acquire the private South San Francisco, Calif.-based drug developer Kai Pharmaceuticals for $315 million, the companies said Tuesday.

January 12, 2012

Active Health Foods rolls out Active X bar for dialysis patients

Active Health Foods has introduced an energy bar designed for dialysis patients.

January 11, 2012

Fleming sells medical products to Valeant

Fleming Pharmaceuticals has sold rights of several of its products to Valeant International, Fleming said Wednesday.

June 3, 2011

HbA1C test may not be useful among dialysis patients with diabetes

The gold standard long-term glucose monitoring test for patients with diabetes proved to be of limited value in dialysis patients, according to a new study at Wake Forest Baptist Medical Center released Wednesday.

March 7, 2011

Keryx to present phase-3 clinical data for Zerenex at conference

Late-stage clinical trial data for a Keryx Biopharmaceuticals drug to treat kidney disease will be presented at a medical conference in Las Vegas.

February 8, 2011

Vascugel granted fast-track designation by FDA

The Food and Drug Administration has given expedited review to a drug for preventing hemodialysis failure in patients with end-stage kidney disease.

December 1, 2010

Keryx: Zerenex reduces phosphate levels in patients on kidney dialysis

Drug maker Keryx Biopharmaceuticals got promising results from a late-stage clinical trial of a drug for treating elevated phosphate levels, also known as hyperphosphatemia, in patients on kidney dialysis, the company said Tuesday.

October 25, 2010

Keryx to commence phase-3 trial for Zerenex

Drug maker Keryx Biopharmaceuticals has finished enrolling participants for a late-stage clinical trial of a...

September 28, 2010

Keryx commences phase-3 trial for Zerenex

Keryx has begun its phase-3 clinicial trial of a drug designed to treat elevated serum...

July 5, 2010

Impax challenges Renvela patent

Generic drug maker Impax Labs is challenging the patent on a drug used to treat...

May 5, 2010

Keryx enrolls patients in Zerenex trial

Keryx Biopharmaceuticals has started a late-stage clinical trial of a drug for patients on kidney...